Publications by authors named "J Boitnott"

Article Synopsis
  • Faculty members prioritize fair and transparent salary policies, expecting compensation to be competitive with the market and aimed at attracting and retaining talent.
  • The salary structure in the pathology department consists of three components: base salary based on rank and years, additional compensation for defined roles, and a performance-based bonus (part C) that incentivizes contributions to the department’s goals.
  • Recent changes to part C have transitioned to a more objective evaluation system focused on research productivity, educational excellence, and clinical improvements, allowing faculty to better understand and track their compensation outcomes.
View Article and Find Full Text PDF

Hepatocellular carcinomas exhibit heterogeneous morphologies by routine light microscopy. Although some morphologies represent insignificant variations in growth patterns, others may represent unrecognized subtypes of hepatocellular carcinoma. Identification of these subtypes could lead to separation of hepatocellular carcinomas into discrete groups with unique underlying genetic changes, prognosis, or therapeutic responses.

View Article and Find Full Text PDF
Article Synopsis
  • Gaucher disease type 2 is a rare lysosomal storage disorder that usually appears between 3 to 6 months old, causing neurodegeneration and typically leading to death within the first 2 years.
  • The case presented discusses a newborn with cholestasis and liver biopsy findings of giant-cell transformation, initially misdiagnosed as giant-cell hepatitis, highlighting the challenges in diagnosing neonatal onset Gaucher disease.
  • This example suggests that neonatal cholestasis could signify a broader range of symptoms in Gaucher disease, potentially linking classic type 2 and perinatal lethal forms of the disease, with giant cells indicating a systemic inflammatory response.
View Article and Find Full Text PDF
Article Synopsis
  • Since 2006, cotesting (HPV DNA and Pap testing) for cervical cancer screening in women aged 30 and older has been recommended, but actual adoption in clinical settings has been limited.
  • Over a 2.5-year study, the percentage of cotests for women aged 30 and older rose from 15.9% to 39.4%, showing an increase in appropriate criteria adherence.
  • In contrast, cotesting for women aged 18 to 29 initially grew but then declined significantly to 7.7%, indicating ongoing issues with age-inappropriate testing practices.
View Article and Find Full Text PDF